Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05678738 · ClinicalTrials.gov registry record · NA

Acquiring and Targeting Heat Exposures Necessary for Action

A NA study of Heat Stress and Fatigue; Heat, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT05678738: Completed NA study of Heat Stress and Fatigue; Heat, sponsored by University of Connecticut.

NCT05678738 is a NA study of Heat Stress and Fatigue; Heat that has completed, run by University of Connecticut. The registered enrollment target is 108 participants, above the 47-participant average among 5 other Heat Stress trials with a reported enrollment target (130% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05678738, a NA study of Heat Stress and Fatigue; Heat, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. The main questions this project aims to answer are: 1. What is the relative stress contributing to performance differences between women and men during intense exercise in extremely hot and humid environments in response to exertional heat stress? 2. What is the relative contribution of responses in adipose tissue, cardiovascular tissue, gut microbiota, and musculoskeletal tissue on heat tolerance in women (vs. men) to exertional heat stress? 3. What is the impact of adding an antioxidant juice consumption regime and will it assist in enhancing performance during an acute bout of exercise-heat stress before and after heat acclimation? Subjects enrolled and approved for participation will perform: 1. a heat acclimation protocol which includes the completion of 5 days of prescribed exercise-heat exposure 2. two separate acute exercise-heat exposures for the assessment of thermotolerance and the investigation of potential enhancements in thermoregulatory performance that may occur after the completion of a 5-day heat acclimation protocol 3. a subset of subjects enrolled and approved for participation who opt in to antioxidant berry supplement consumption will either consume the active or placebo product throughout their participation.

Primary Outcome

Rectal thermometer will be self-inserted by participants to assess core temperature prior to exercise-heat stress bouts

Interventions

  • DIETARY_SUPPLEMENT Antioxidant Berry Supplementation
  • OTHER Acute and Chronic Exercise-Heat Stress
  • DIETARY_SUPPLEMENT Placebo (non-juice) Supplementation

Study Locations (1)

Connecticut

  • Human Performance Laboratory at the University of Connecticut - Storrs

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2021-09-16
Est. Completion 2024-04-17
Phase NA
University of Connecticut

107 total trials

What the finished NCT05678738 record still lists

NCT05678738 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 47-participant average among 5 other Heat Stress trials with a reported enrollment target (130% higher).

The record links to 3 conditions, with Heat Stress appearing as the primary indexed condition, and to 3 interventions - of which Antioxidant Berry Supplementation is the first listed.

NCT05678738 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT05678738 about?

NCT05678738 is a clinical study titled "Acquiring and Targeting Heat Exposures Necessary for Action". The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. The main question...

What is the current status of trial NCT05678738?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2021-09-16. Estimated completion is 2024-04-17.

What conditions does trial NCT05678738 study?

This clinical trial studies the following conditions: Heat Stress, Fatigue; Heat, Heat Intolerance.

What interventions are being tested in trial NCT05678738?

The interventions under investigation include: Antioxidant Berry Supplementation (DIETARY_SUPPLEMENT), Acute and Chronic Exercise-Heat Stress (OTHER), Placebo (non-juice) Supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05678738?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05678738 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heat Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05678738, the US trial registry maintained by the National Library of Medicine. NCT05678738 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.